Navigation Links
BIO-key Retains Former Senior FBI Official as Strategic Advisor and Consultant
Date:9/21/2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... inhabited our planet for more than 4 billion years ... by as many eons more. That suggests they may ... Tel Aviv University bacteria expert Prof. Eshel Ben-Jacob of ... Astronomy, grounded in the study of bacteria, presents compelling ... most people should not automatically opt for the swine ...
(Date:12/16/2009)... of Maryland School of Medicine researcher will lead the ... prominent scientists in the field of stem cell research. ... Medicine, was chosen by the National Heart, Lung and ... consortium of national experts, which will be called the ... be funded by a $30 million grant over seven ...
(Date:12/16/2009)... Calif., Dec. 1 GestureTek Inc. ... Release 3.0 - a turnkey, portable, plug ... advertising, exhibits, entertainment and touring promotions. GestureTek ... of patents in camera-enabled gesture recognition technology ... ,, Guaranteed for quality, the CUBE has ...
Breaking Biology News(10 mins):Bacteria wouldn't opt for a swine flu shot 2Bacteria wouldn't opt for a swine flu shot 3University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 3GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 3Centene Corporation to Present at Bank of America Merrill Lynch Credit Conference 61862 1Nevada Health Care Association 28NHCA 29 Supports Majority Leader Reid 61859 1Unilens Vision Reports Record First Quarter Earnings and Royalty Income 6445 1Unilens Vision Reports Record First Quarter Earnings and Royalty Income 6445 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 6445 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 6445 4
... Yale biomedical engineers have devised a rapid and efficient ... activation and expansion, an immune response important for a ... to an advance on line report in Molecular Therapy. ... , assistant professor of biomedical engineering at ...
... important crop species that is unsuited to the Agrobacterium-based ... with crops. Researchers, reporting in the open access journal ... and reverse genetics tool for the pea (Pisum sativum), ... world.. , Researchers from the INRA Plant Genomics Research ...
... An ambitious expedition led by scientists at Scripps Institution ... of little-known islands in the central Pacific Ocean has ... and threats from human activities. , The exploration of ... chain approximately a thousand miles south of Hawaii, has ...
Other Biology News:Yale scientists create artificial 'cells' that boost the immune response to cancer 2Scientists unravel the genetic coding of the pea 2Scripps expedition provides new baseline for coral reef conservation 2Scripps expedition provides new baseline for coral reef conservation 3
(Date:12/16/2009)... Trial conducted pursuant to Special Protocol Assessment ... QUEBEC CITY, Dec. 16 /PRNewswire-FirstCall/ - AEterna ... AEZ) (the "Company"), a global biopharmaceutical company ... announced the initiation, by its partner Keryx ... Phase 3 registration clinical trial for perifosine ...
(Date:12/16/2009)... Nu-Tek BioSciences, LLC introduces HSP-A Soy Peptone. HSP A has ... , ... (PRWEB) December 16, 2009 -- Nu-Tek BioSciences, ... by introducing HSP-A Soy Peptone. HSP-A, previously manufactured by Nutricepts, ... is proven to improve growth rates and yields. HSP-A has ...
(Date:12/15/2009)... BioEnergy Institute (JBEI), one of three Department of Energy ... time-stamping service to protect its valuable intellectual property. ... ... (PRWEB) December 15, 2009 -- Surety, LLC , ... , today announced that the Joint BioEnergy Institute (JBEI), ...
(Date:12/15/2009)... NEW YORK, Dec. 15 Reportlinker.com ... is available in its catalogue: ,, ... - Market Forecasts to 2015, Pipeline Analysis ... http://www.reportlinker.com/p0168104/The-Future-of-Orphan-Diseases-Therapeutics---Market-Forecasts-to-2015-Pipeline-Analysis-and-Reimbursement.html ,, Summary ... latest research "The Future of Orphan Diseases ...
Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 2Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 4Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 6Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 7Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 8Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 9Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 10Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 11Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 12Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 13Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 14Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 15Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 16Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 17Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 18
... CITY, Calif., Dec. 28 Maxygen, Inc.,(Nasdaq: ... development of,improved protein drugs, today announced that it ... on Monday, January 7, 2008 at,9:00 a.m. Pacific ... Vetticaden, Maxygen,s chief medical officer, will present. A,live ...
... vote suggests broad stockholder support for proposed Raven ... ... VXGN), a biopharmaceutical company, announced today that,its stockholders approved the proposed reverse split ... with approximately 80% of stock voting.,The resolution permits VaxGen to reverse split its ...
... 27 Schering-Plough,Corporation (NYSE: SGP ) is scheduled ... fourth quarter and full year on Tuesday, Feb. 12,2008., ... will conduct a conference,call to review results for the ... chairman and CEO, and other members of management,will host ...
Other Biology Technology:VaxGen Stockholders Overwhelmingly Approve Reverse Split Proposal 2VaxGen Stockholders Overwhelmingly Approve Reverse Split Proposal 3VaxGen Stockholders Overwhelmingly Approve Reverse Split Proposal 4Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result 2
... Radiolabeled Ligands\n\nReceptor-related research has long been enabled ... ligands selected to keep pace with new ... products and services for receptor research and ... If you do not find exactly what ...
... consists of an anodized aluminum body in ... Compounds embedded in polymerized matrix. It is ... and Synergy Multi-Detection Readers. This multi-functional test ... reducing the need for tedious wet testing. ...
... Feature Extraction Software reads ... files to prepare microarray data ... , * one 2-year ... for NFP/Academic accounts , * ...
... Agarose and SYBR Safe DNA Gel Stain combo offers ... versus buying these same products separately ... ethidium bromide Eliminates risks ... DNA and RNA fragments from 100 bp to >30 ...
Biology Products: